Market Place
Sourcing Support
Lupin`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
27 Mar 2024 //
FDA
Hetero`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
03 Aug 2023 //
FDA
Alkem`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
07 Dec 2022 //
FDA
Aurobindo`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
21 Oct 2022 //
FDA
Dr Reddys Labs` Generic Eslicarbazepine Acetate Receives Approval in the U.S
29 Jun 2021 //
FDA
BIAL takes the lead in Europe for the of epilepsy treatment, Zebinix®
18 Feb 2021 //
PHARMIWEB
SPH Shanghai `s Eslicarbazepine Acetate Receives Supplemental Approval in US
17 Jun 2020 //
FDA
Alkem`s Generic Eslicarbazepine Acetate Receives Tentative Approval in US
28 Jan 2019 //
FDA
Eisai and Bial report new clinical practice data for Zebinix
08 Oct 2018 //
PHARMACEUTICAL TECHNOLOGY
Aptiom® (Eslicarbazepine Acetate) : Bial - Portela & CA S.A v. Hetero Labs
08 Mar 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate) : Bial - Portela v. Jubilant Life Sciences
01 Mar 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate):Bial - Portela & CA S.A. v. Jubilant
01 Mar 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate):Bial - Portela & CA S.A. v. Alkem Laboratories
22 Feb 2018 //
PATENT LITIGATION
Zebinix non-inferior to current standard of care in epilepsy
02 Feb 2018 //
PHARMA TIMES
Real world data back use of Eisai, Bial’s Zebinix in epilepsy
15 Dec 2017 //
PHARMA TIMES
EU regulators widen approval for Zebinix
25 May 2017 //
PHARMA TIMES
Neurocrine & BIAL Announce North American Licensing Agreement for Opicapone
09 Feb 2017 //
PR NEWSIWRE
New data from post-marketing Zebinix® (eslicarbazepine acetate) collected for six years
30 May 2016 //
PR NEWS WIRE
New data from post-marketing Zebinix® (eslicarbazepine acetate) collected
30 May 2016 //
PR NEWS WIRE
BIAL and Eisai provide new data known, by which once a day Zebinix® (eslicarbazepine acetate) as monotherapy
19 Apr 2016 //
PR NEWS WIRE
Presented new data, the use of Zebinix to treat partial onset seizure at AES
09 Dec 2015 //
PR NEWS WIRE
Zebinix® (eslicarbazepine acetate) in the treatment of partial seizures
07 Dec 2015 //
PR NEWS WIRE
PsychoGenics Achieves Another Milestone in Drug Discovery Collaboration with Sunovion
27 Jan 2015 //
BUSINESS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.